Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the target of a significant decline in short interest in the month of June. As of June 15th, there was short interest totaling 1,023 shares, a decline of 63.1% from the May 31st total of 2,772 shares. Based on an average daily trading volume, of 7,852 shares, the short-interest ratio is presently 0.1 days.
Carl Zeiss Meditec Price Performance
Carl Zeiss Meditec stock opened at $30.98 on Monday. The stock has a 50-day moving average price of $30.41 and a 200 day moving average price of $34.20. Carl Zeiss Meditec has a 52 week low of $26.65 and a 52 week high of $67.53.
Analyst Ratings Changes
Separately, Zacks Research downgraded Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research report on Monday, May 25th. One investment analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Carl Zeiss Meditec currently has a consensus rating of “Hold”.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
Featured Articles
- Five stocks we like better than Carl Zeiss Meditec
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
